Mounjaro and Hashimoto's: Using Tirzepatide with an Underactive Thyroid

You've been managing Hashimoto's for years, and the weight still won't shift

It's a frustration our prescribers hear regularly. You've had your levothyroxine dose adjusted, your TSH is now in range, and still the scales barely move. That experience is common and, importantly, it has a biological explanation. Hashimoto's (an autoimmune attack on the thyroid that leaves many people with hypothyroidism) alters metabolism in ways that persist even after hormone levels are corrected. The thyroid doesn't just affect weight through thyroxine output; it influences how the body responds to appetite signals, stores energy, and maintains muscle mass. So when someone with Hashimoto's asks whether Mounjaro could help, the question is reasonable. What matters is understanding exactly what tirzepatide does, and how it sits alongside a condition and a medication regime you may already have in place.

Tirzepatide works by activating two gut-hormone receptors (GIP and GLP-1) that are involved in appetite regulation and blood-sugar control. It slows gastric emptying, reduces hunger signals reaching the brain, and in clinical trials produced average weight reductions of around 20–21% over 72 weeks at the 15mg dose, as reported in the SURMOUNT-1 trial, published in the New England Journal of Medicine. Those results were in people with obesity or overweight with weight-related conditions, Hashimoto's wasn't an exclusion criterion.

If you'd like to explore the broader topic of tirzepatide as a medicine before going further, that's a good starting point alongside this page.

The thyroid-cancer caution: what it means for Hashimoto's patients specifically

Mounjaro carries a specific contraindication that sometimes causes alarm when people with any thyroid condition read it: a personal or family history of medullary thyroid carcinoma (MTC), or a condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN2). This comes from rodent studies in which GLP-1 receptor activation was associated with thyroid C-cell changes at very high doses. Those findings have not been replicated in human data, and MTC is a cancer of the C-cells, which are different from the follicular cells damaged by Hashimoto's autoimmunity.

Hashimoto's thyroiditis is not medullary thyroid carcinoma. The two conditions involve entirely different cell types and mechanisms. Having Hashimoto's does not, by itself, place you in the contraindicated group. A prescriber completing your clinical assessment will check for any personal or family history of MTC or MEN2 as a standard step, it is part of the screening, not a reason to assume you can't be prescribed it. The NHS tirzepatide medicines page summarises the contraindications and who should discuss their history carefully before starting.

People with Hashimoto's who also have a goitre, thyroid nodules, or a more complicated thyroid history should mention all of this at consultation. A prescriber may want your most recent thyroid function results before approving treatment, that's not a barrier, it's good clinical practice. You can read more about what our team considers on the clinical team page.

Levothyroxine timing and the gastric-emptying effect

This is probably the most practically important point for anyone already on thyroid medication. Levothyroxine absorption is sensitive. It's best taken on an empty stomach, usually 30–60 minutes before food, and clear of anything that competes for absorption, including calcium, iron and certain antacids. Tirzepatide slows gastric emptying as part of its mechanism of action. That means food and other substances move through the stomach more slowly than usual, which can alter the absorption window for medicines taken orally.

In practice, the advice most prescribers give is straightforward: keep your levothyroxine at its usual time, first thing in the morning with water, well before eating, and tell your GP you've started tirzepatide so they can arrange a thyroid function check in the weeks after you begin. It is a simple one-minute habit to build in before the rest of your morning routine, and it may protect the consistency of your thyroid levels during any early adjustment period. If your Hashimoto's symptoms feel different after starting Mounjaro (more fatigue, cold sensitivity, brain fog) that warrants a GP conversation and a TSH recheck, rather than assuming it's the tirzepatide causing the problem directly. Some patients also ask about whether Mounjaro affects erectile dysfunction, which is a related question worth reviewing if it's relevant to your situation.

For a broader look at how tirzepatide sits alongside autoimmune and neurological conditions, our tirzepatide and Hashimoto's page covers additional considerations, and our Mounjaro and MS page addresses a related question about autoimmune conditions more widely.

Eligibility, private access, and what to tell your prescriber

Mounjaro is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition. Hashimoto's-related hypothyroidism doesn't appear on the formal list of qualifying comorbidities used for NICE's NHS commissioning criteria, but it's a condition that any thorough prescriber will want to know about. For private prescribing, the eligibility framework follows the licensed indications rather than NICE's NHS thresholds, and some people with Hashimoto's will meet the standard BMI criteria in their own right.

The NHS rollout for tirzepatide is phased and focuses on specific comorbidities; cost and access context for private prescribing are worth understanding before you decide which route suits you. If you're already on tirzepatide and have questions about another aspect of daily life on the medicine, the general FAQs page covers a range of practical topics.

At consultation with a nume prescriber, being upfront about your Hashimoto's diagnosis, your levothyroxine dose, how well-controlled your thyroid function is, and any recent blood results will help them build an accurate picture. Treatment decisions with any autoimmune thyroid condition in the background require a careful clinical read, which is exactly what a GPhC-registered Independent Prescriber carries out before anything is approved. If you're ready to have that conversation, you can start your free consultation and our team will review your full history the same day.